back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Symmes, Tricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+334,863 vol |
1,634,863 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Symmes, Tricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+500,000 vol $0.12 each |
1,300,000 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Symmes, Tricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
800,000 | |
| Filed 2016-11-08 Tx date 2016-11-01 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Symmes, Tricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-08 Tx date 2016-11-04 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Symmes, Tricia
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+500,000 vol $0.18 each |
500,000 |